Alan Wells
Department of Pathology
Pittsburgh VAMC and University of Pittsburgh
Pittsburgh
PA 15261
USA
Name/email consistency: high
- Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Wells, A., Souto, J.C., Solava, J., Kassis, J., Bailey, K.J., Turner, T. Clin. Cancer Res. (2002)
- Growth factor-induced cell motility in tumor invasion. Wells, A., Kassis, J., Solava, J., Turner, T., Lauffenburger, D.A. Acta. Oncol (2002)